Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A yearly strategy formalizes harvest windows, helping you optimize tax outcomes while staying invested in index funds.
22,166 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
When a company's top executive sells a large chunk of stock, investors take note. This article dives into Privia Heal...
Stock splits don’t change a business’s fundamentals, but they can spark buying interest. Learn how to find an unbelie...
A Perdoceo director recently exercised 9,308 options and sold shares, triggering questions for investors. This guide ...
Facing a pullback, Bitcoin still offers two compelling catalysts for action before June 2026. Learn the data-backed r...
With rates and yields shifting in 2026, experts say building $12,000 a month from dividends hinges on yield mix and g...
Google’s Gmail guru unveils a three-adopter framework for AI use, signaling a trust-first approach as Gmail rolls out...
New projections show the Social Security trust fund could exhaust sooner than expected, prompting a bold plan to rely...
When retirement planning feels uncertain, claiming Social Security at 62 can provide a reliable income floor. This ar...
When a company’s top executive sells stock, investors want to know why. This deep dive explains BlackSky's sold over ...
As millions of Baby Boomers retire, a fundamental shift is underway for markets and investment strategies. This story...
A Magnite insider disclosed a sizable open-market sale, sparking questions for investors. This guide breaks down what...